# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-054149
Filing Date
2024-04-29
Accepted
2024-04-29 17:02:08
Documents
8
Period of Report
2024-06-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2410169-1_def14a.htm | DEF 14A | 682231
2 | GRAPHIC | bc_investment-4clr.jpg | GRAPHIC | 56378
3 | GRAPHIC | bc_investmenttsr-4clr.jpg | GRAPHIC | 60402
4 | GRAPHIC | bc_netincome-4clr.jpg | GRAPHIC | 58271
5 | GRAPHIC | bc_netloss-4clr.jpg | GRAPHIC | 53757
6 | GRAPHIC | px_armataproxy1pg1-bw.jpg | GRAPHIC | 250974
7 | GRAPHIC | px_armataproxy1pg2-bw.jpg | GRAPHIC | 240539
8 | GRAPHIC | sg_robinckramer-bw.jpg | GRAPHIC | 8233
| Complete submission text file | 0001104659-24-054149.txt |  | 1621476

Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 24892342
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)